You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

CLINICAL TRIALS PROFILE FOR GADOBENATE DIMEGLUMINE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for GADOBENATE DIMEGLUMINE

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00323310 ↗	Safety and Efficacy of MultiHance in Pediatric Patients	Terminated	Bracco Diagnostics, Inc	Phase 3	2006-04-01	The purpose of this study was to assess the safety and enhancing properties of the magnetic resonance imaging (MRI) contrast agent MultiHance in children aged 2 to 17 years having central nervous system (CNS) disorders.
NCT00395863 ↗	Multihance at 3 Tesla (3T) in Brain Tumors	Completed	Bracco Diagnostics, Inc	Phase 4	2006-11-01	Compare the efficacy of MultiHance and Magnevist
NCT01165892 ↗	Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar)	Completed	Lantheus Medical Imaging		2011-07-01	The use of the contrast agent, Ablavar, will help with the diagnosis of pulmonary embolism in magnetic resonance imaging (MRI).
NCT01165892 ↗	Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar)	Completed	Washington University School of Medicine		2011-07-01	The use of the contrast agent, Ablavar, will help with the diagnosis of pulmonary embolism in magnetic resonance imaging (MRI).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for GADOBENATE DIMEGLUMINE

Condition Name

Chart
Table

Condition Name for GADOBENATE DIMEGLUMINE
Intervention	Trials
Adult Supratentorial Primitive Neuroectodermal Tumor	1
Adenocarcinoma	1
Cognitive Function	1
Multiple Sclerosis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for GADOBENATE DIMEGLUMINE
Intervention	Trials
Brain Neoplasms	3
Nervous System Diseases	2
Central Nervous System Diseases	2
Neuroectodermal Tumors, Primitive	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for GADOBENATE DIMEGLUMINE

Trials by Country

Map
Table

Trials by Country for GADOBENATE DIMEGLUMINE
Location	Trials
United States	22
Korea, Republic of	1
Czech Republic	1
Italy	1
Poland	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for GADOBENATE DIMEGLUMINE
Location	Trials
Illinois	3
Massachusetts	2
California	2
Michigan	2
New Jersey	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for GADOBENATE DIMEGLUMINE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for GADOBENATE DIMEGLUMINE
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	2
Phase 2	5
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for GADOBENATE DIMEGLUMINE
Clinical Trial Phase	Trials
Completed	7
Recruiting	4
Terminated	3
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for GADOBENATE DIMEGLUMINE

Sponsor Name

Chart
Table

Sponsor Name for GADOBENATE DIMEGLUMINE
Sponsor	Trials
Bracco Diagnostics, Inc	5
National Cancer Institute (NCI)	5
Guerbet	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for GADOBENATE DIMEGLUMINE
Sponsor	Trials
Other	13
Industry	8
NIH	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.